| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.23824 |
| P8608 | Fatcat ID | release_tmi2y2dz7zedzlf5ggwsauabtq |
| P932 | PMC publication ID | 4045008 |
| P698 | PubMed publication ID | 24382825 |
| P50 | author | Tejal A. Desai | Q7695186 |
| Vuk Uskoković | Q37829335 | ||
| P2860 | cites work | Diagnosis and management of osteomyelitis | Q27009101 |
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications | Q33842947 | ||
| Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting | Q34258878 | ||
| Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells. | Q34275320 | ||
| Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers | Q34426254 | ||
| Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents | Q34733812 | ||
| The safety of chitosan as a pharmaceutical excipient | Q35005613 | ||
| Infection, inflammation, and bone regeneration: a paradoxical relationship | Q35205143 | ||
| Harnessing and modulating inflammation in strategies for bone regeneration. | Q35570026 | ||
| Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model | Q35677162 | ||
| Interaction between osteoblast and osteoclast: impact in bone disease | Q35891193 | ||
| Common dietary supplements for weight loss. | Q35956452 | ||
| Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives | Q36795351 | ||
| A tense situation: forcing tumour progression | Q37112264 | ||
| Microbial polysaccharides and their derivatives as current and prospective pharmaceuticals. | Q37347356 | ||
| The epidemiology of revision total knee arthroplasty in the United States | Q37483428 | ||
| Low molecular weight and oligomeric chitosans and their bioactivities. | Q37630683 | ||
| Chitosan-based delivery systems for protein therapeutics and antigens | Q37635353 | ||
| Amorphous calcium phosphates: synthesis, properties and uses in biomaterials | Q37694806 | ||
| Advances in using chitosan-based nanoparticles forin vitroandin vivodrug and gene delivery | Q37788222 | ||
| Polymers in small-interfering RNA delivery | Q37900314 | ||
| Inflammation and axon regeneration | Q37941990 | ||
| Chitosan derivatives with antimicrobial, antitumour and antioxidant activities--a review | Q37954738 | ||
| Chitosan-based drug delivery systems | Q38007844 | ||
| Hydrogels in calcium phosphate moldable and injectable bone substitutes: Sticky excipients or advanced 3-D carriers? | Q38064182 | ||
| Dynamic Light Scattering Based Microelectrophoresis: Main Prospects and Limitations | Q38125672 | ||
| Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis. | Q39147816 | ||
| Electrospun biomimetic scaffold of hydroxyapatite/chitosan supports enhanced osteogenic differentiation of mMSCs | Q39249100 | ||
| Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation | Q39314529 | ||
| Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis | Q39335755 | ||
| Synthesis, characterization and preliminary in vitro evaluation of PTH 1-34 loaded chitosan nanoparticles for osteoporosis. | Q39362330 | ||
| Antimicrobial actions of degraded and native chitosan against spoilage organisms in laboratory media and foods | Q39484470 | ||
| Infection burden for hip and knee arthroplasty in the United States | Q39848742 | ||
| Low molecular weight molecules of oyster nacre induce mineralization of the MC3T3-E1 cells | Q40087466 | ||
| Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. | Q40349236 | ||
| In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells | Q40380474 | ||
| Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells | Q40404949 | ||
| Temporal zeta potential variations of 45S5 bioactive glass immersed in an electrolyte solution | Q40764923 | ||
| Local antibiotic therapy in osteomyelitis | Q41034784 | ||
| Crystal alignment of carbonated apatite in bone and calcified tendon: results from quantitative texture analysis | Q41648748 | ||
| Antifungal activity of chitosan nanoparticles and correlation with their physical properties. | Q42094388 | ||
| Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. | Q42453910 | ||
| Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation | Q42579707 | ||
| Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. | Q42603653 | ||
| Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response | Q42829153 | ||
| Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells | Q42829301 | ||
| Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. | Q42910759 | ||
| Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells | Q43123738 | ||
| Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release | Q43197764 | ||
| Growth and osteogenic differentiation of alveolar human bone marrow-derived mesenchymal stem cells on chitosan/hydroxyapatite composite fabric | Q43594477 | ||
| Gentamicin-impregnated chitosan/nanohydroxyapatite/ethyl cellulose microspheres granules for chronic osteomyelitis therapy. | Q43639209 | ||
| Biomimetic chitosan-calcium phosphate composites with potential applications as bone substitutes: preparation and characterization. | Q43805478 | ||
| Prenatal and developmental effect of high molecular weight chitosan (HMWCS) to mice | Q43939365 | ||
| Water absorption and degradation characteristics of chitosan-based polyesters and hydroxyapatite composites | Q44650325 | ||
| Influence of molecular weight on oral absorption of water soluble chitosans | Q45226225 | ||
| Effects of chitosan particles in periodontal pathogens and gingival fibroblasts. | Q45986016 | ||
| Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. | Q46286880 | ||
| Structural study of octacalcium phosphate bone cement conversion in vitro. | Q46289577 | ||
| The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation | Q46657800 | ||
| Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2). | Q46929707 | ||
| A combined chitosan/nano-size hydroxyapatite system for the controlled release of icariin | Q47344057 | ||
| Actinomycotic osteomyelitis of the facial bones and mandible | Q47609904 | ||
| Relationship between antibacterial activity of chitosan and surface characteristics of cell wall | Q50098689 | ||
| Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. | Q51188499 | ||
| Study on drug release behaviour of CDHA/chitosan nanocomposites--effect of CDHA nanoparticles. | Q51249588 | ||
| In vitro study of human vascular endothelial cell function on materials with various surface roughness. | Q51615822 | ||
| Antibiotic delivery system using nano-hydroxyapatite/chitosan bone cement consisting of berberine. | Q51870160 | ||
| Tetracycline adsorption on chitosan: a mechanistic description based on mass uptake and zeta potential measurements. | Q52627276 | ||
| Bio-composite scaffolds containing chitosan/nano-hydroxyapatite/nano-copper-zinc for bone tissue engineering. | Q54347795 | ||
| The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer | Q57173514 | ||
| Effects of chitin and chitosan particles on BALB/c mice by oral and parenteral administration | Q73304328 | ||
| Preparation and characterization of nano-hydroxyapatite/chitosan/konjac glucomannan composite | Q80475329 | ||
| Reoperation rate in diaphyseal tibia fractures | Q82201613 | ||
| Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation | Q82798208 | ||
| Preparation and biocompatibility of nanohybrid scaffolds by in situ homogeneous formation of nano hydroxyapatite from biopolymer polyelectrolyte complex for bone repair applications | Q83379967 | ||
| Chitosan implants in the rat spinal cord: biocompatibility and biodegradation | Q83782700 | ||
| T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles | Q84166924 | ||
| Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms | Q84175544 | ||
| Fabrication, characterization and cell cultures on a novel composite chitosan-nano-hydroxyapatite scaffold | Q84350214 | ||
| In vivo drug release and antibacterial properties of vancomycin loaded hydroxyapatite/chitosan composite | Q84600483 | ||
| Chitosan adsorption on hydroxyapatite and its role in preventing acid erosion | Q84645566 | ||
| Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites | Q84672350 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| osteomyelitis | Q938983 | ||
| drug delivery | Q1392806 | ||
| P304 | page(s) | 567-579 | |
| P577 | publication date | 2013-12-30 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis | |
| P478 | volume | 103 |
| Q58585447 | Bacteriocin Isolated from Lactobacillus Rhamnosus L34 Has Antibacterial Effects in a Rabbit Model of Infection After Mandible Fracture Fixation |
| Q92934545 | Biowaste-Derived Hydroxyapatite for Effective Removal of Reactive Yellow 4 Dye: Equilibrium, Kinetic, and Thermodynamic Studies |
| Q46924536 | Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma |
| Q38897354 | Chlorhexidine-loaded hydroxyapatite microspheres as an antimicrobial delivery system and its effect on in vivo osteo-conductive properties. |
| Q58768791 | Coatings as the useful drug delivery system for the prevention of implant-related infections |
| Q34050315 | Does translational symmetry matter on the micro scale? Fibroblastic and osteoblastic interactions with the topographically distinct poly(ε-caprolactone)/hydroxyapatite thin films |
| Q47102427 | Nanomedicine for safe healing of bone trauma: Opportunities and challenges |
| Q28086953 | Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis |
| Q47220439 | Nonlinear Oscillatory Dynamics of the Hardening of Calcium Phosphate Bone Cements. |
| Q47750657 | One Ion to Rule Them All: Combined Antibacterial, Osteoinductive and Anticancer Properties of Selenite-Incorporated Hydroxyapatite |
| Q38733439 | Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor |
| Q35787138 | Sustained release of VH and rhBMP-2 from nanoporous magnesium-zinc-silicon xerogels for osteomyelitis treatment and bone repair |
| Q38861520 | The use of nanomaterials to treat bone infections |
| Q30368848 | When 1+1>2: Nanostructured composites for hard tissue engineering applications |
Search more.